The biosimilar developer, which has closed a funding round led by Livzon Mabpharm, will take a majority share in the merged entity.

Johnson & Johnson has invested an undislosed amount in the venture, which will seek to commercialise biomedical technology developed by Scripps.

Healthy living app Lifesum has secured $6.7m in its series A round, which featured publishing group Bauer Media.

The healthcare company's corporate venturing unit is among the investors in Assembly's first major funding round.

Mainstay Medical is set to raise up to $36.4m from its initial public offering, with existing shareholder Medtronic to take some of the stock.

VC firm Qiming Venture Partners has closed its Fund IV at $500m after Mayo Clinic returned as a limited partner.

The company will develop novel technology that will help guide the effective use of antibiotics and other antimicrobial therapeutics.

Spero, which is developing treatments for bacterial infections, has also set to secure funding through a partnership with Roche.